Xcout Intel
Epitopea competitors & alternatives
The 12 closest competitors and alternatives to Epitopea among biotechnology companies — ranked by similarity to what Epitopea actually does, not by market-cap band.
Subscribe to see Epitopea’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Epitopea
Epitopea is a transatlantic cancer immunotherapeutics company operating from Montreal, Canada, and Cambridge, United Kingdom. Backed by life-science investors, the company develops novel therapeutics utilizing its proprietary CryptoMap platform.
Epitopea at a glance
Epitopea is a biotechnology company headquartered in Canada. It has raised at least $45M across the 2 funding rounds on record. Its most recent funding round, Pre-Series A, raised $31M in October 2024. Xcout tracks 5 named people at Epitopea, including Dr. Alan C. Rigby (CEO).
Epitopea leadership
- Dr. Alan C. RigbyCEO
- Klaus EdvardsenCMO
- Claude PerreaultFounder
- Pierre ThibaultFounder
- Bryan KellyVice-President, Finance
Epitopea funding rounds
At least $45M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Series A | $31M | 11 named | |
| — | $14M | 11 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Epitopea competitors
Ranked by semantic similarity — how close each company is to Epitopea by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotech
Enara Bio, Ltd. is a UK biotechnology company that discovers cancer targets, including tumor-specific antigens, using immunopeptidomics and machine-learning technologies. It works with biopharmaceutical companies to support development of cancer vaccines and other targeted immunotherapies.
Similar biotechnology company
Nested Therapeutics is a privately held biotech company headquartered in Cambridge, Massachusetts, focused on advancing precision oncology medicine by uncovering hidden driver mutations.
Similar biotechnology company
Actithera, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on delivering targeted radioligand cancer therapies.
Biotech
Immatics is a biopharmaceutical company that develops T cell-based immunotherapies and bispecific product candidates to treat various types of cancer. The company focuses on precision targeting of the PRAME protein expressed in multiple solid tumors, serving cancer patients with high unmet medical needs.
Biotech
Elicera Therapeutics is a clinical-stage immuno-oncology company that develops genetically engineered cell and gene therapies, including CAR T-cell therapies and oncolytic viruses, to treat various types of cancer. The company utilizes its proprietary iTANK technology platform to enhance the immune system's ability to target and attack solid tumors.
Similar biotechnology company
Neogap Therapeutics is a privately held clinical-stage biopharmaceutical company founded in 2016 and located at the Cancer Center Karolinska in Stockholm, Sweden. The company focuses on immuno-oncology and is developing personalized therapies for cancer treatment.
Biotech
Altamira Therapeutics Ltd. is a biotechnology company developing RNA-based cancer therapies using its proprietary xPhore nanoparticle delivery technology. Its lead candidate, ATX-402, is designed to systemically deliver therapeutic mRNA to reprogram the tumor microenvironment and improve cancer immunotherapy outcomes for patients.
Similar biotechnology company
OneChain Immunotherapeutics is a biotechnology company based in Barcelona focused on the development of CAR-T cell therapies and in vivo platforms for cancer immunotherapy.
Similar biotechnology company
DCx Biotherapeutics is a Canadian preclinical-stage biotechnology company developing precision oncology therapeutics and precision drug conjugates to target genetically defined cancers. The company focuses on addressing root drivers and key cellular interdependencies of cancer lesions.
Similar biotechnology company
NextPoint Therapeutics is a private biopharmaceutical and technology company based in Cambridge, Massachusetts, focused on expanding novel therapeutic possibilities.
Life Sciences
OncXerna Therapeutics is a clinical-stage precision-oncology biotechnology company that develops RNA-based biomarkers and targeted cancer therapies. Its work is intended to help identify cancer patients most likely to benefit from particular treatments and support oncologists and pharmaceutical partners in treatment selection.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Epitopea and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Epitopeaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →